Compare Merck & Co., Inc. (MRK) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs VanEck Semiconductor ETF — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while VanEck Semiconductor ETF trades at $603.33 (market cap $73.92B). The key difference: Merck & Co., Inc. is far larger — about 4.8× VanEck Semiconductor ETF's market cap, and Merck & Co., Inc. pays a 2.39% dividend while VanEck Semiconductor ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and VanEck Semiconductor ETF for 101 Days on average.
| MRK | SMH | |
|---|---|---|
Market Cap | $351.28B | $73.92B |
Volume | 7,969,665 | 11,050,892 |
Sector | Health | — |
52-Week High | $156.43 | $668.91 |
52-Week Low | $82.49 | $325.10 |
Typical Hold Time | 98 Days | 101 Days |
Enterprise Value | $398.04B | — |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $65.01 billion in 2025, and net income reached $18.25 billion. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, with institutional investors increasing stakes.
The outlook for Merck is supported by analyst consensus with a $158.78 price target and 68% buy ratings, but risks include high valuation multiples like a P/E of 113.9 and competitive pressures in the pharma sector. The stock's investment appeal hinges on pipeline execution and integration of acquisitions amid a challenging technical backdrop.
SMH (VanEck Semiconductor ETF) trades at $606.82, down 2.91% on the day but maintains a bullish technical outlook with strong moving average support. The semiconductor sector shows robust performance with the ETF up approximately 69% year-to-date through September 2026, significantly outpacing the broader market. Recent industry developments include AMD's $8.2 billion acquisition of World Labs, expanding AI capabilities across the semiconductor ecosystem.
The semiconductor sector's structural growth driven by AI adoption presents continued upside potential, though concentration risk in top holdings like Nvidia and cyclical industry volatility remain key considerations. Technical support at $597 and resistance at $620 define near-term trading ranges, with the overall bullish trend supported by strong sector fundamentals and institutional interest.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
